Bardin Hill Management Partners LP Axonics, Inc. Transaction History

Bardin Hill Management Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.3 - $69.67 $9.54 Million - $9.87 Million	141,688 Added 134.24%	247,233 $17.2 Million
Q2 2024 Aug 13, 2024	SELL	$66.47 - $69.65 $172,356 - $180,602	-2,593 Reduced 2.4%	105,545 $7.1 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $6.13 Million - $7.5 Million	108,138 New	108,138 $7.46 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Bardin Hill Management Partners LP, based on Form 13F filings with the SEC.

Stay updated on Bardin Hill Management Partners LP with notifications on news.